Akebia Therapeutics Inc’s filing revealed that its CEO and President Butler John P. unloaded Company’s shares for reported $84928.0 on Mar 03 ’25. In the deal valued at $1.83 per share,46,409 shares were sold. As a result of this transaction, Butler John P. now holds 2,557,921 shares worth roughly $7.47 million.
Then, Burke Steven Keith sold 7,144 shares, generating $13,074 in total proceeds. Upon selling the shares at $1.83, the SVP, Chief Medical Officer now owns 809,090 shares.
Before that, Burke Steven Keith bought 7,144 shares. Akebia Therapeutics Inc shares valued at $13,086 were divested by the Officer at a price of $1.83 per share.
Leerink Partners initiated its Akebia Therapeutics Inc [AKBA] rating to an Outperform in a research note published on April 28, 2025; the price target was $7. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. H.C. Wainwright revised its rating on August 28, 2023. It rated AKBA as “a Buy” which previously was an “a Neutral”.
Price Performance Review of AKBA
On Tuesday, Akebia Therapeutics Inc [NASDAQ:AKBA] saw its stock jump 2.10% to $2.92. Over the last five days, the stock has gained 4.29%. Akebia Therapeutics Inc shares have risen nearly 53.68% since the year began. Nevertheless, the stocks have risen 165.45% over the past one year. While a 52-week high of $2.97 was reached on 05/27/25, a 52-week low of $0.80 was recorded on 04/10/25. SMA at 50 days reached $2.24, while 200 days put it at $1.87.
Levels Of Support And Resistance For AKBA Stock
The 24-hour chart illustrates a support level at 2.86, which if violated will result in even more drops to 2.80. On the upside, there is a resistance level at 2.98. A further resistance level may holdings at 3.03. The Relative Strength Index (RSI) on the 14-day chart is 69.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 8.80%. Stochastics %K at 86.88% indicates the stock is a selling.
